Johnson & Johnson's Third Loss Over Ovarian Cancer Link to Talcum Powder
Last month, a jury awarded a California woman more than $70,000,000.00 after alleging that Johnson & Johnson’s talc-based products contributed to her development of ovarian cancer.
The 62-year-old woman used Johnson & Johnson’s baby powder for feminine hygiene purposes for more than 40 years until she was diagnosed with stage IV ovarian cancer in 2012., Her doctors revealed she has an 80% chance of passing away in the next two years after undergoing radiation, chemotherapy, and surgical procedures.The plaintiffs’ counsel argued Johnson & Johnson was aware of studies which showed the increased risks of ovarian cancer from the use of talc powder products. They also maintained the company developed a strategy to prevent government regulation of its products instead of providing warning labels.
More than 1,700 women have accused Johnson & Johnson of ignoring studies which link its Shower-to-Shower® and baby powder talcum powder products to ovarian cancer and failing to warn consumers about the dangers of the products. The October verdict, follows the previous talc claim verdicts of $55,000,000.00 and $72,000,000.00 against Johnson & Johnson this year in St. Louis court. Johnson & Johnson plan on appealing all three cases.
The jury ordered Johnson & Johnson to pay $65,000,000.00 in punitive damages and about $2,500,000.00 for medical expenses. In addition, the jury ordered Imerys Talc America, the supplier of the talc powder, to pay $2,500,000.00 in exemplary damages.